Dr. Jess Silva-Fisher
banner
jesssfisher.bsky.social
Dr. Jess Silva-Fisher
@jesssfisher.bsky.social
RNA biologist, Cancer expert, leader and mentor, Tejana, WashU Med, silvafisherlab.com
Pinned
Hola Silva-Fisher Lab @WashUDepartmentMeds! I'm a #RNACancerBiologist. My lab studies #lncRNAs and RNA modifications in #MultipleMyeloma #breastcancer and guide the #NextGen of #STEM trainees.
silvafisherlab.com
Research lab | Jessica Silva-Fisher | United States
Jessica Silva-Fisher, PhD Research lab at Washington University in St. Louis studying lncRNA and cancer metastasis.
silvafisherlab.com
Reposted by Dr. Jess Silva-Fisher
OPEN FOR GRAD APPLICATIONS!! The NEW RNA Therapeutics & Biology Program in the Basic Biomedical Sciences PhD program develops leaders. Register for the workshop to get qs answered ahead of Dec 1, 2025 app deadline.
Admission Workshop Tues, Nov 18, 2025: direc.to/nA7S
November 14, 2025 at 5:00 PM
Reposted by Dr. Jess Silva-Fisher
📢 FINAL CALL! Don't miss your chance to apply for ASH CHAMP—a year-long opportunity to be paired with an expert mentor in classical hematology.

🔗https://ow.ly/fLYQ50Xjb19

#HemeSky #HemeOnc #MedSky
November 4, 2025 at 12:45 PM
Reposted by Dr. Jess Silva-Fisher
Check how this study highlights LINC01432 as a potential therapeutic target for overcoming resistance in high-risk multiple myeloma.
November 4, 2025 at 8:02 AM
Reposted by Dr. Jess Silva-Fisher
"Investigation of lncRNA expression in newly diagnosed multiple myeloma reveals a LINC01432-CELF2 axis as an inhibitor of apoptosis"

🔵 Jessica Silva-Fisher latest and outstanding research is now available to read in #Oncogenesis.

▶️ Read the open access article here: www.nature.com/articles/s41...
November 4, 2025 at 8:02 AM
#SilvaFisherlab Halloween pics 🎃
October 30, 2025 at 11:11 PM
Say Hi to Luna! #Frenchie
October 30, 2025 at 11:08 PM
Reposted by Dr. Jess Silva-Fisher
Named one of St. Louis’ most exciting startups to watch in
@stltoday.com, Wugen is redefining the future of cancer care. The WashU-born biotech standout recently raised $115M to advance a modified cell-based therapy found to work in 91% of patients. www.stltoday.com/news/local/b...
Nicklaus: With $115 million in hand, biotech startup eyes the finish line
Wugen has become a standout among St. Louis biotech startups. It has raised more than $300 million in capital since 2018 and employs about 35 people.
www.stltoday.com
October 22, 2025 at 2:59 PM
Reposted by Dr. Jess Silva-Fisher
I just made an account and voted for this biology laboratory made of LEGO to "promote biological research and inspire more people into the world of biology". They need 10K votes. Reposting and/or voting below would be helpful. 🤗
beta.ideas.lego.com/product-idea...
Biological Laboratory | LEGO® Ideas
This is a two-floor realistic Biological Laboratory building. In this design, I try to tell stories about biologists, introduce biology concepts to general publ…
beta.ideas.lego.com
October 16, 2025 at 8:07 AM
Reposted by Dr. Jess Silva-Fisher
Please nominate or apply for an RNA Society Award by October 20th!
www.rnasociety.org/awards
October 16, 2025 at 9:01 AM
Thank you to @uarizona.bsky.social 2025 Joint Biology Retreat Graduate Student Committee for inviting me to be their Keynote Speaker!Amazing time learning about the innovative research being led by grad students and new faculty. Speaking at #Biosphere2 was truly a historic experience.#SilvaFisherlab
October 15, 2025 at 7:06 PM
Thrilled to share our new paper! 🧬 link.springer.com/article/10.1...

We show how this lncRNA–protein interaction impacts cell survival in #multiplemyeloma.

Huge thanks to all co-authors and especially the students for their incredible work! 🙌
#SilvaFisherlab #RNA #lncRNA
Investigation of lncRNA expression in newly diagnosed multiple myeloma reveals a LINC01432-CELF2 axis as an inhibitor of apoptosis - Oncogenesis
Multiple myeloma (MM) is an incurable malignancy of plasma cells, with over 35,000 new cases diagnosed annually in the United States. Despite an expanding arsenal of approved therapies, nearly all pat...
link.springer.com
October 14, 2025 at 9:34 PM
Reposted by Dr. Jess Silva-Fisher
Your research on hematologic diseases and disorders that disproportionately affect vulnerable communities is too vital to be threatened by federal funding cuts!

The ASH Treating Fairly Research Award supports researchers now. Apply: https://ow.ly/PIwH50Xb9mX #Fight4Hematology #Hemesky #Medsky
October 14, 2025 at 3:45 PM
Reposted by Dr. Jess Silva-Fisher
Save the Date for RNA 2026 in Montreal, Canada!
October 14, 2025 at 3:51 PM
Reposted by Dr. Jess Silva-Fisher
Since 2012, the ASH Bridge Grant has funded 205 researchers with $28M, leading to $680M in follow-on NIH funding. These grants keep labs running and fuel breakthroughs in hematology. Learn more: https://bit.ly/48yINrB
October 10, 2025 at 8:01 PM
Reposted by Dr. Jess Silva-Fisher
🔗: medicine.washu.edu/news/washu-m... WashU Medicine’s innovative fellow-to-faculty programs — including RISE, Cori, and Dean’s fellows— are attracting sought-after postdoctoral talent for their unique opportunities, which help accelerate career advancement into professorship.
October 10, 2025 at 4:52 PM
Reposted by Dr. Jess Silva-Fisher
RNA journal Call for Papers on RNA-based Therapeutics, Diagnostics, and Disease!
October 6, 2025 at 4:59 AM
Reposted by Dr. Jess Silva-Fisher
ASH CHAMP is now accepting applications! This unique year-long program connects trainees with expert mentors in classical hematology—especially helpful if your institution lacks robust mentorship in this area.

🔗Apply today: https://bit.ly/46D9AAb

#HemeSky #HemeOnc #MedSky
September 29, 2025 at 5:16 PM
#Charcuterie Friday!
September 26, 2025 at 9:38 PM
Joining #PedalTheCause virtually! 🚴‍♀️ Not a big biker, so I’ll be running instead 🏃‍♀️

Running for my mom + dad 💪 (survivors) and in memory of my grandma + grandfather in-law +cousin 💛

Let’s push for a world without cancer. 🌍✨ #CancerResearch #EndCancer
@sitemancenter.bsky.social #SilvaFisherlab
September 13, 2025 at 5:41 PM
Reposted by Dr. Jess Silva-Fisher
Applications are now open for ASH trainee awards! Whether you’re a medical student, resident, or hematologist, these awards provide mentorship, funding, research opportunities, and more.

Apply today and take your next big step: https://bit.ly/4mFbcAc

#ASHAwards #HemeSky
ASH Awards - Hematology.org
ASH provides many awards and programs to support hematologists in all stages of their careers and to honor those who have helped to advance the field of hematology.
bit.ly
September 5, 2025 at 6:30 PM
Reposted by Dr. Jess Silva-Fisher
Study finds when women bosses were more assertive, thus deviating from gender norms, they felt depleted, incompetent, anxious, overwhelmed & more withdrawn. But men didn't experience stress over gender expectations, whether they were kind or stern.
news.uga.edu/women-constr...
Women are constrained by gender stereotypes in leadership roles - UGA Today
A new UGA study reveals the destructive effects of gender norms and expectations for female bosses and how it affects their ability to lead.
news.uga.edu
August 28, 2025 at 11:57 PM
Reposted by Dr. Jess Silva-Fisher
Every clinician benefits from the right mentor.

The new ASH Malignant Hematology Mentorship Program is now open for applications—offering fellows a chance to build lasting connections, receive career guidance, and grow within malignant hematology.

🔗 https://bit.ly/3IPWjMA
August 29, 2025 at 11:25 AM
Reposted by Dr. Jess Silva-Fisher
Application for 2025/2026 RNA Salons is now open. Please apply by 31st August to receive support your local or regional RNA activities. @rnasociety.bsky.social #Lexogen www.rnasociety.org/salons
www.rnasociety.org
August 17, 2025 at 8:32 AM